Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Global eTicket Exchange Ltd. v. Ticketmaster L.L.C. et al
Case Number:
6:21-cv-00399
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 26, 2023
Ticketmaster Seeks $3.6M Fees For Beating 'Weak' Patent Suit
Ticketmaster asked a Texas federal judge Thursday to award $3.6 million in attorney fees and interest for beating at trial Global eTicket Exchange's claims that Ticketmaster's ticket-scanning technology infringes its patent, arguing Global eTicket "doggedly" and improperly litigated the meritless case using irrelevant evidence of Ticketmaster's alleged market dominance.
-
May 04, 2023
Ticketmaster Didn't Infringe Sales Tech Patent, Jury Says
A Texas federal jury cleared Ticketmaster of allegations that it infringed a rival's patent on ticket sales technology.
-
May 01, 2023
Ticketmaster Can't Tune Out 'Will-Call' Tech Patent Suit
A Texas federal judge has rebuffed Ticketmaster's bid to wipe out a pair of a rival's patents on ticket sales technology right before the parties began a jury trial on Monday, refusing also to clear the ticketing giant of most infringement claims.
-
April 27, 2023
IP Forecast: Gov't To Face Off Against Gilead In Delaware
In one of its first-ever patent infringement cases against a private company, the federal government next week will argue before a Delaware jury that Gilead is making billions of dollars in sales from HIV treatments that allegedly violate government-owned patents. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.